A recent Futurism article discussed a new development that could yield the same benefits of gastric bypass surgery without the surgery part. A team of researchers at Brigham and Women’s Hospital believes that weight loss isn’t necessarily the key to curing Type 2 Diabetes. They’ve developed a compound they call LuCl (Luminal Coating of the Intestine) using an FDA-approved drug called sucralfate as a base. The compound temporarily coats the lining of the intestine and makes it unable to absorb nutrients.